Close
Nordic 9Nordic 9

Blue Goose Capital (investor - Venture Capital)

United States bluegoosecap.com
See something wrong or missing? Let us know
Offices:Cambridge

Blue Goose Capital is an investment company from Spain backing biopharma, data and device companies at seed stage to Series B across the US and Spain.

Average round investment:570k USD
Average number per year:1.0
Distribution: 2022 (1)
Portfolio companies: Spain AtG Therapeutics
Mostly invests in: Spain Spain (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Blue Goose Capital

Name Criteria
Spain Laboratorios Labiana
73%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Spain Inveniam
73%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Finland Sauli Törmälä
70%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Damien Lane
70%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Finland Avohoidon Tutkimussäätiö
70%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Vasa Angels
70%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Gobia Enterprises
70%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Sweden Västkusten Affärsänglar
70%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Netherlands UNIIQ
70%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Denmark Accelerace
70%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Top